Fertility Services Market Insights Across Key Regions

The global fertility services market size was valued at USD 48.15 billion in 2025 and is projected to grow from USD 51.19 billion in 2026 to USD 85.80 billion by 2034, growing at a CAGR of 6.67% during the forecast period (2026–2034).

The increasing prevalence of infertility, delayed parenthood trends, growing awareness regarding assisted reproductive technologies (ART), and advancements in fertility treatment procedures are driving significant growth in the fertility services market worldwide. The rising acceptance of fertility treatments among both men and women, coupled with supportive government initiatives and expanding healthcare infrastructure, continues to strengthen market demand.

• North America dominated the global fertility services market and accounted for the largest market share.

• Asia-Pacific is projected to be the fastest-growing region during the forecast period.

• Based on procedure type, the in-vitro fertilization (IVF) segment held the largest market share.

• The egg and embryo banking segment is expected to witness the fastest growth during the forecast period.

• Fertility clinics emerged as the leading end-user segment globally.

• Increasing technological advancements in reproductive healthcare are supporting market expansion.

The growing incidence of infertility among both men and women is one of the primary factors driving the global fertility services market. Lifestyle changes, rising stress levels, obesity, smoking, alcohol consumption, hormonal disorders, and delayed pregnancies have significantly contributed to infertility rates worldwide. Additionally, increasing awareness regarding fertility preservation and assisted reproductive technologies has encouraged more individuals and couples to seek fertility treatments.

Furthermore, advancements in fertility treatment technologies, including in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo freezing, and genetic screening, are improving treatment success rates and patient outcomes. Expanding healthcare infrastructure, rising medical tourism for fertility procedures, and favorable reimbursement policies in several countries are also fueling market growth.

Despite significant advancements, the high cost associated with fertility treatments remains a major challenge for market growth. Procedures such as IVF and egg freezing often require multiple treatment cycles, making them financially burdensome for many patients. Limited insurance coverage for fertility treatments in several countries further restricts accessibility and adoption.

Additionally, ethical concerns and social stigma associated with assisted reproductive technologies in certain regions continue to hinder market expansion. Regulatory challenges related to embryo storage, surrogacy, and fertility procedures may also impact market development across different countries.

The increasing trend of fertility preservation among working professionals and cancer patients is expected to create substantial growth opportunities for the market. Rising demand for egg freezing, sperm banking, and embryo preservation services is expanding the scope of fertility service providers globally.

Moreover, the rapid expansion of fertility clinics in emerging economies, combined with increasing investments in reproductive healthcare technologies, is anticipated to open new revenue streams for market players. Growing acceptance of same-sex parenting and single-parent fertility treatments is also expected to positively influence market growth during the forecast period.

• Vitrolife AB

• CooperSurgical Inc.

• Merck KGaA

• FUJIFILM Irvine Scientific

• Genea Limited

• Bloom Fertility Centre

• Monash IVF Group

• Apollo Fertility

• Mayo Clinic

• The Johns Hopkins Hospital

• CARE Fertility

• Nova IVF Fertility

• In-Vitro Fertilization (IVF)

• Artificial Insemination

• Intracytoplasmic Sperm Injection (ICSI)

• Surrogacy

• Egg and Embryo Banking

• Others

• Fertility Clinics

• Hospitals

• Surgical Centers

• Clinical Research Institutes

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

North America holds the dominant position in the fertility services market owing to the presence of advanced healthcare infrastructure, increasing infertility rates, high awareness regarding fertility treatments, and strong adoption of advanced reproductive technologies. The region also benefits from the presence of leading fertility clinics and favorable reimbursement frameworks.

Asia-Pacific is anticipated to witness the fastest growth during the forecast period due to increasing healthcare expenditure, rising awareness regarding infertility treatments, expanding medical tourism, and growing investments in reproductive healthcare infrastructure. Countries such as China, India, and Japan are emerging as major fertility treatment hubs.

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/fertility-services-market

Explore comprehensive market trends, competitive landscape analysis, growth opportunities, and future outlook in the global fertility services market report.

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Email: sales@straitsresearch.com

Tel: 1 646 905 0080 (U.S.), 44 203 695 0070 (U.K.)